Doiron R Christopher, Tripp Dean A, Tolls Victoria, Nickel J Curtis
Department of Urology, Queen's University, Kingston, ON, Canada.
Department of Psychology, Queen's University, Kingston, ON, Canada.
Can Urol Assoc J. 2018 Jun;12(6):196-202. doi: 10.5489/cuaj.4876. Epub 2018 Feb 23.
Two decades of increasing understanding of etiopathogenesis and clinical phenotyping produces an impression the clinical face of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is changing. We sought to retrospectively analyze trends in CP/CPPS patients presenting to our clinic for evaluation over a 16-year period.
Patients with CP/CPPS presenting to a tertiary clinic were evaluated prospectively from 1998-2014 with Chronic Prostatitis Symptom Index (CPSI) and UPOINT (urinary, psychosocial, organ-specific, infection, neurogenic, and tenderness) categorization. Patients were stratified in four cohorts, based on year of presentation, and we retrospectively analyzed variations in symptom scores and patterns, UPOINT categorization, and treatment modalities amongst cohorts.
Mean age of the 1310 CP/CPPS patients was 44.7 years, while mean CPSI pain, urination, and total scores were 10.6, 4.8, and 23.3, respectively. The most prevalent UPOINT domain, urinary (U) (71.8%) was associated with a higher CPSI urination score (6.3), more frequent penile tip pain (37%), dysuria (48%), and more treatment with alpha-blockers (70%). Increase in UPOINT domains was associated with higher CPSI pain, quality of life (QoL), and total scores. Trends over time included increased prevalence of psychosocial (P), organ (O), and tenderness (T) domains, as well as increased use of alpha-blockers, neuromodulation, and phytotherapy as treatment modalities. There was little variation in age, CPSI scores, and pain locations over time.
The changing clinical face of CP/CPPS reflects the increased recognition of psychosocial (P domain) and pelvic floor pain (T domain), along with the concomitant use of associated therapies. There was little variation of pain/urinary symptom patterns and QoL.
二十年来,对慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)病因发病机制和临床表型的认识不断加深,给人一种印象,即CP/CPPS的临床面貌正在发生变化。我们试图回顾性分析16年间到我们诊所就诊评估的CP/CPPS患者的趋势。
1998年至2014年,对到三级诊所就诊的CP/CPPS患者进行前瞻性评估,采用慢性前列腺炎症状指数(CPSI)和UPOINT(泌尿、心理社会、器官特异性、感染、神经源性和压痛)分类法。根据就诊年份将患者分为四个队列,我们回顾性分析了各队列之间症状评分和模式、UPOINT分类以及治疗方式的差异。
1310例CP/CPPS患者的平均年龄为44.7岁,而CPSI疼痛、排尿和总分的平均值分别为10.6、4.8和23.3。最常见的UPOINT领域是泌尿(U)(71.8%),其与较高的CPSI排尿评分(6.3)、更频繁的阴茎头疼痛(37%)、排尿困难(48%)以及更多地使用α受体阻滞剂治疗(70%)相关。UPOINT领域的增加与较高的CPSI疼痛、生活质量(QoL)和总分相关。随着时间的推移,趋势包括心理社会(P)、器官(O)和压痛(T)领域的患病率增加,以及作为治疗方式的α受体阻滞剂、神经调节和植物疗法的使用增加。年龄、CPSI评分和疼痛部位随时间变化不大。
CP/CPPS不断变化的临床面貌反映了对心理社会(P领域)和盆底疼痛(T领域)的认识增加,以及相关疗法的同时使用。疼痛/泌尿症状模式和QoL变化不大。